GlassScriptPhysician profile
Erik Morgan Berger
NPI 1003120502
$1,353.60
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Sports Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $283 · 2021: $253 · 2022: $134.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $255.03 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $194.57 | 2019-2021 | |
| Novo Nordisk INC | $102.09 | 2019-2020 | |
| Lilly USA, LLC | $98.14 | 2019-2021 | |
| Amarin Pharma, INC. | $85.36 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $67.75 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $56.84 | 2019-2021 | |
| Pfizer INC. | $55.55 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $53.86 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.17 | 2019 | |
| Abbott Laboratories | $51.01 | 2019-2022 | |
| Glaxosmithkline, LLC. | $48.24 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $45.30 | 2019 | |
| Astellas Pharma US INC | $33.46 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $20.27 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.72 | 2019 | |
| Hikma Pharmaceuticals USA | $19.51 | 2020 | |
| Shire North American Group INC | $17.88 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.50 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.40 | 2019 | |
| Boston Scientific Corporation | $17.15 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.76 | 2019 | |
| Pacira Therapeutics, INC. | $11.04 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.